Quadrivalent inactivated influenza vaccine (VaxigripTetra™)

Quadrivalent inactivated influenza vaccine (VaxigripTetra™)

Introduction: VaxigripTetra™ (IIV4; Sanofi Pasteur) is a quadrivalent split-virion influenza vaccine approved in Europe in 2016 for individuals ≥ 3 years of age. IIV4 builds on the well-established record of the trivalent split-virion influenza vaccine (Vaxigrip®). Areas covered: This literature rev...

Full description

Bibliographic Details
Main Authors: Viviane Gresset-Bourgeois, Phillip S. Leventhal, Stéphanie Pepin, Rosalind Hollingsworth, Marie-Pierre Kazek-Duret, Iris De Bruijn, Sandrine I. Samson
Format: Article
Language:English
Published: Taylor & Francis Group 2018-01-01
Series:Expert Review of Vaccines
Subjects:
clinical trial
immunogenicity
inactivated influenza vaccine
influenza b
quadrivalent influenza vaccine
safety
Online Access:http://dx.doi.org/10.1080/14760584.2018.1407650

Internet

http://dx.doi.org/10.1080/14760584.2018.1407650

Similar Items